West Pharmaceutical Services PE Ratio 2006-2019 | WST

Current and historical p/e ratio for West Pharmaceutical Services (WST) from 2006 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. West Pharmaceutical Services PE ratio as of February 14, 2020 is 53.88.
West Pharmaceutical Services PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2020-02-14 174.57 73.97
2019-12-31 150.33 $2.36 63.70
2019-09-30 141.82 $3.05 46.50
2019-06-30 125.15 $3.03 41.30
2019-03-31 110.20 $2.90 38.00
2018-12-31 97.89 $2.75 35.60
2018-09-30 123.13 $2.06 59.77
2018-06-30 98.88 $2.00 49.44
2018-03-31 87.79 $1.76 49.88
2017-12-31 97.97 $1.99 49.23
2017-09-30 95.43 $2.51 38.02
2017-06-30 93.58 $2.34 39.99
2017-03-31 80.67 $2.43 33.20
2016-12-31 83.72 $1.92 43.61
2016-09-30 73.40 $1.85 39.67
2016-06-30 74.64 $1.37 54.48
2016-03-31 68.07 $1.15 59.19
2015-12-31 59.01 $1.30 45.39
2015-09-30 52.92 $1.28 41.34
2015-06-30 56.69 $1.69 33.54
2015-03-31 58.65 $1.83 32.05
2014-12-31 51.75 $1.76 29.41
2014-09-30 43.40 $1.66 26.15
2014-06-30 40.80 $1.60 25.50
2014-03-31 42.51 $1.51 28.15
2013-12-31 47.25 $1.58 29.91
2013-09-30 39.55 $1.55 25.52
2013-06-30 33.68 $1.40 24.14
2013-03-31 31.03 $1.19 26.08
2012-12-31 26.07 $1.15 22.77
2012-09-30 25.18 $1.12 22.59
2012-06-30 23.87 $1.15 20.85
2012-03-31 20.02 $1.21 16.61
2011-12-31 17.78 $1.08 16.46
2011-09-30 17.30 $0.90 19.22
2011-06-30 20.33 $0.91 22.34
2011-03-31 20.72 $0.94 22.16
2010-12-31 18.99 $0.94 20.20
2010-09-30 15.74 $1.15 13.74
2010-06-30 16.66 $1.14 14.62
2010-03-31 19.08 $1.12 17.12
2009-12-31 17.76 $1.06 16.75
2009-09-30 18.33 $1.03 17.88
2009-06-30 15.66 $0.98 16.06
2009-03-31 14.68 $1.10 13.34
2008-12-31 16.82 $1.25 13.45
2008-09-30 21.66 $1.09 19.97
2008-06-30 19.14 $1.07 17.98
2008-03-31 19.50 $1.02 19.12
2007-12-31 17.84 $1.03 17.40
2007-09-30 18.24 $1.15 15.86
2007-06-30 20.59 $1.17 17.68
2007-03-31 20.22 $1.11 18.22
2006-12-31 22.25 $1.00 22.25
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $12.917B $1.840B
West Pharmaceutical Services, Inc. is a global drug delivery technology company that applies proprietary materials science, formulation research and manufacturing innovation to advance the quality, therapeutic value, development speed and rapid market availability of pharmaceuticals, biologics, vaccines and consumer healthcare products. West is the world's premiere provider of standard-setting systems and device components for parenterally administered medicines and an emerging leader in the development of advanced formulation technologies for the transmucosal delivery of drugs. West contract manufacturing harnesses a powerful combination of innovation, technology, infrastructure and expertise to serve the pharmaceutical, medical and consumer industries. Along with more than 50 years of experience, they bring customers quality, safety and reliability in injection molding, contract assembly and finished packaging.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $70.565B 22.38
McKesson (MCK) United States $29.730B 11.66
Align Technology (ALGN) United States $21.670B 55.43
AmerisourceBergen (ABC) United States $19.428B 13.03
Laboratory Of America Holdings (LH) United States $18.962B 17.27
Cardinal Health (CAH) United States $17.396B 10.86
Cooper (COO) United States $17.371B 28.61
Straumann Holding AG (SAUHF) Switzerland $15.709B 0.00
DENTSPLY SIRONA (XRAY) United States $12.867B 25.15
Henry Schein (HSIC) United States $10.584B 19.71
CONMED (CNMD) United States $2.976B 39.57
Merit Medical Systems (MMSI) United States $2.259B 26.39
Patterson (PDCO) United States $2.203B 16.32
STAAR Surgical (STAA) United States $1.644B 85.84
Atrion (ATRI) United States $1.268B 34.94
Antares Pharma (ATRS) United States $0.583B 357.00
Invacare (IVC) United States $0.302B 0.00
Lifevantage (LFVN) United States $0.226B 18.93
Pro-Dex (PDEX) United States $0.073B 20.14
Biolase (BIOL) United States $0.021B 0.00
Endologix (ELGX) United States $0.015B 0.00